Faster and more cost-effective trials support early-stage research in China driving the country's drug discovery engine.

uniQure will run another trial of its Huntington’s Disease gene therapy following the FDA’s review. Credit: Vink Fan / Shutterstock.com uniQure’s stock has dropped by more than 40% after being asked ...

Mahzi Therapeutics has dosed the first patient in its Phase I/II UNITE study assessing MZ-1866, an investigational gene ...

Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010.

Novo Nordisk and United Laboratories’ jointly developed triple G drug has achieved a 19.7% weight loss in a Phase II trial in ...

Patients with HIV showed lower cases of steatotic liver disease when switched to ViiV Healthcare’s Dovato compared to ...

In the trial, CagriSema appeared to have a safe and well-tolerated profile. The most common adverse events with CagriSema ...

C4 Therapeutics has dosed the first patient in its Phase II MOMENTUM trial of cemsidomide, an oral IKZF1/3 degrader, combined with dexamethasone for patients with RRMM.

The US Food and Drug Administration (FDA) has issued more information to sponsors regarding its “plausible mechanism pathway” ...

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, ...

Teva Pharmaceuticals and Sanofi’s monoclonal antibody (mAb) has shown durable clinical and endoscopic efficacy in a Phase IIb ...

Compass will now seek approval for COMP360 in TRD, which could become the first classic psychedelic to gain the FDA’s ...